News

News

January 2, 2019
AnaptysBio to Present at J.P. Morgan 37th Annual Healthcare Conference
SAN DIEGO , Jan. 02, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria , chief executive officer of AnaptysBio , will
Displaying 11 - 13 of 13